NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT
Post# of 153
HeartBeam (NASDAQ: BEAT), a medical technology company revolutionizing cardiac care, announced its participation in the JP Morgan 2025 Annual Healthcare Conference, set for Jan. 13-16, 2025, in San Francisco. CEO Robert Eno and CFO Timothy Cruickshank will meet with investors and potential partners to discuss the recently FDA-cleared HeartBeam system, the first cable-free, credit card-sized ECG device designed for comprehensive arrhythmia assessment. Combining its patented high-fidelity ECG technology with AI-driven analysis, HeartBeam aims to provide a longitudinal view of cardiac health, transforming cardiovascular diagnostics and predictive care for millions of patients worldwide.
NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://nnw.fm/BEAT
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer